Pituitary Tumor-Transforming 2 (PTTG2) Peptide
PTTG2
Reactivité: Humain
Hôte: Synthetic
WB, BP
-
- Antigène Tous les produits PTTG2
- PTTG2 (Pituitary Tumor-Transforming 2 (PTTG2))
- Origine
- Humain
-
Source
- Synthetic
- Application
- Western Blotting (WB), Blocking Peptide (BP)
- Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-PTTG2 antibody (Catalog #: ARP50542_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Antigène
- PTTG2 (Pituitary Tumor-Transforming 2 (PTTG2))
- Synonymes
- pituitary tumor-transforming 2 Peptide, PTTG2 Peptide
- Sujet
-
PTTG2 belongs to the securin family. The N-terminal destruction box (D-box) acts as a recognition signal for degradation via the ubiquitin-proteasome pathway.
Alias Symbols: -
Protein Size: 191 - Poids moléculaire
- 21 kDa
- ID gène
- 10744
- NCBI Accession
- NM_006607, NP_006598
-
Vous êtes ici:
